Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
02/2012
02/16/2012US20120040888 Anti-infective hydroxy-phenyl-benzoates and methods of use
02/16/2012US20120040887 Composition for the treatment of osteomyelitis, method for preparing the same, and method for the treatment of osteomyelitis
02/16/2012US20120040033 Anti-infective mangrove extract against viruses, bacteria and fungi
02/16/2012US20120040020 Compounds useful as inhibitors of atr kinase
02/16/2012US20120040012 Therapeutic stem cell nutrient composition and uses thereof
02/16/2012US20120040010 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
02/16/2012US20120039996 Uses of red yeast rice in treating dengue virus infection
02/16/2012US20120039984 Glycopeptide and uses thereof
02/16/2012US20120039978 Novel Anti-Viral Method
02/16/2012US20120039965 Enhanced antimicrobial activity compositions of blends of plant essential oils
02/16/2012US20120039956 Dry storage stabilizing composition for biological materials
02/16/2012US20120039946 Immunopotentiating composition and process for producing same
02/16/2012US20120039945 Methods Of Immune Modulation
02/16/2012US20120039942 Outer membrane vesicles and uses thereof
02/16/2012US20120039939 Compositions and methods for vaccine and virus production
02/16/2012US20120039938 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
02/16/2012US20120039937 Induction of an immune response against dengue virus using the prime-boost approach
02/16/2012US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
02/16/2012US20120039935 Methods of treating measles infectious disease in mammals
02/16/2012US20120039933 Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine
02/16/2012US20120039932 Lentiviral Vectors Pseudotyped with a Sindbis Virus Envelope Glycoprotein
02/16/2012US20120039928 Medicinal plants extract using processing of herbal medicine and composition of skin external application comprising the same
02/16/2012US20120039926 Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells
02/16/2012US20120039925 Tuberculosis tb vaccine to prevent reactivation
02/16/2012US20120039924 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
02/16/2012US20120039923 Modified HIV-1 Envelope Proteins
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039916 Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039905 The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
02/16/2012US20120039899 Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
02/16/2012US20120039898 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
02/16/2012US20120039894 Identification of therapeutic agents for hiv infection
02/16/2012US20120039877 E1-minus adenoviruses and use thereof
02/16/2012US20120039876 Stabilized liquid anti-rsv antibody formulations
02/16/2012US20120039871 Methods and compositions for antibody therapy
02/16/2012US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
02/16/2012US20120039860 Compositions and methods for improved oral health
02/16/2012US20120039858 Methods and compositions for inhibiting propagation of viruses using recombinant tetherin constructs
02/16/2012US20120039850 HCV Combination Therapies Comprising Pegylated Interferon, Ribavirin and Telaprevir
02/16/2012US20120039848 Hepatitis c virus inhibitors
02/16/2012US20120039847 Hepatitis C Virus Inhibitors
02/16/2012US20120039846 Hepatitis c antibodies and uses thereof
02/16/2012US20120039845 Nucleoside prodrugs and uses thereof
02/16/2012US20120039844 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation
02/16/2012US20120039842 Compositions and methods that enhance an immune response
02/16/2012US20120039822 Desensitizing dentifrice
02/16/2012US20120039820 Antibacterial composition comprising 4-isopropyl-3-methylphenol and zinc ions
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012US20120039797 Antibody Therapy
02/16/2012US20120038073 Spray drying methods and related compositions
02/16/2012CA2808061A1 Hepatitis c virus inhibitors
02/16/2012CA2807747A1 Anti-microbial metal organic frameworks
02/16/2012CA2807664A1 Anti-hemagglutinin antibody compositions and methods of use thereof
02/16/2012CA2807546A1 Cyclic boronic acid ester derivatives and therapeutic uses thereof
02/16/2012CA2807136A1 Antisense antiviral compounds and methods for treating a filovirus infection
02/16/2012CA2806547A1 Heterocyclic antiviral compounds
02/15/2012EP2418223A2 Single-chain multivalent binding proteins with effector function
02/15/2012EP2417258A1 Bacteriophage compositions for treatment of bacterial infections
02/15/2012EP2417165A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
02/15/2012EP2417141A1 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity
02/15/2012EP2417140A1 Inhibitors of hiv replication
02/15/2012EP2417134A1 Macrocyclic serine protease inhibitors
02/15/2012EP2417133A1 Compounds and methods for antiviral treatment
02/15/2012EP2417122A1 Indole derivatives and methods for antiviral treatment
02/15/2012EP2417120A1 Substituted piperidines as ccr3 antagonists
02/15/2012EP2417108A1 Organic compounds and their uses
02/15/2012EP2416800A1 Oral lactoferrin in the treatment of severe sepsis
02/15/2012EP2416794A1 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c
02/15/2012EP2416772A1 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
02/15/2012EP2416765A1 Hcv inhibitor and therapeutic agent combinations
02/15/2012EP2416761A1 Desfesoterodine in the form of a tartaric acid salt
02/15/2012EP2142192B1 Compositions and kits for treating influenza
02/15/2012EP2102217B1 4- (2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials
02/15/2012EP1971680B1 Method for generating dendritic cells employing decreased temperature
02/15/2012EP1865961B1 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
02/15/2012EP1768666B1 Novel uses of porphyrin compounds
02/15/2012EP1381432B1 HSA-free formulations of interferon-beta
02/15/2012EP1071457B1 Polymer particle vaccine delivery system
02/15/2012CN1939419B 一种由连翘和新鱼腥草素钠制成的药物组合物 One kind Houttuyfonate by forsythia and new pharmaceutical composition made of sodium
02/15/2012CN102356090A Combination gas vaccines and therapeutics
02/15/2012CN102356080A Amorphous salt of macrocyclic inhibitor of hcv
02/15/2012CN102355908A Nanoparticle formulated glycolipid antigens for immunotherapy
02/15/2012CN102355901A Compound for the treatment of tuberculosis
02/15/2012CN102355897A Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
02/15/2012CN102352365A Method for clearing away mycoplasma from pseudorabies vaccine strains
02/15/2012CN102352363A Scylla paramamosain antiviral type lipopolysaccharide resistant factor as well as preparation method and application thereof
02/15/2012CN102352347A Porcin circovirus type 2 (PCV2) recombinant baculovirus construction method and subunit vaccine preparation method thereof
02/15/2012CN102352346A Novel-pathotype duck reovirus and attenuated vaccine thereof
02/15/2012CN102352345A Preparation method of newcastle disease HI antigen
02/15/2012CN102352338A Brucella shell as well as preparation method and application thereof
02/15/2012CN102352330A Bacillus subtilis PA105 and preparation method and application thereof
02/15/2012CN102351937A Acetylated 18-alpha glycyrrhizic acid and preparation method thereof
02/15/2012CN102351932A Structure, preparation method and purpose of anti-influenza virus oligonucleotide
02/15/2012CN102351931A Pyrimidine nucleoside derivatives as well as synthesis method and application thereof in preparation of anti-tumor and antiviral drugs
02/15/2012CN102351927A Borojo active extract and preparation method and antibacterial and anti-oxidation application thereof
02/15/2012CN102351888A Mangiferin aglycon medicinal complex and preparation method and applications thereof
02/15/2012CN102351886A Cefteram pivoxil crystal and preparation method thereof and composition tablets containing crystal
02/15/2012CN102351882A Flucloxacillin sodium compound and preparation method thereof
1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 1798